Thermo Fisher Scientific (TMO) Accumulated Expenses (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Accumulated Expenses for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $1.6 billion, up 10.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 10.29% YoY), and the FY2025 annual result was $2.0 billion, changed 0.35% from the prior year.
• Accumulated Expenses was $1.6 billion for Q1 2026 at Thermo Fisher Scientific, down from $2.0 billion in the prior quarter.
• Over five years, Accumulated Expenses peaked at $2.1 billion in Q4 2022 and troughed at $1.3 billion in Q2 2023.
• Average Accumulated Expenses over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
• Year-over-year, Accumulated Expenses slipped 23.93% in 2023 and gained 24.86% in 2024.
• Over 5 years, Accumulated Expenses stood at $2.1 billion in 2022, then dropped by 23.82% to $1.6 billion in 2023, then increased by 24.56% to $2.0 billion in 2024, then rose by 0.35% to $2.0 billion in 2025, then declined by 21.55% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $1.6 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.9 billion in Q3 2025.